dexmedetomidine has been researched along with Jaundice, Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, H; Wu, F; Xie, Y | 1 |
| Guo, C; Liu, Y; Shi, L; Wu, F; Xie, Y | 1 |
| Cai, MH; Chen, QB; Gao, H; Lu, ZJ; Qiu, HB; Song, JC; Zhang, MZ | 1 |
1 trial(s) available for dexmedetomidine and Jaundice, Obstructive
| Article | Year |
|---|---|
The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Bilirubin; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Jaundice, Obstructive; Male; Middle Aged; Prospective Studies; Tandem Mass Spectrometry | 2018 |
2 other study(ies) available for dexmedetomidine and Jaundice, Obstructive
| Article | Year |
|---|---|
Preventive Effects of Dexmedetomidine on Renal Dysfunction and Hemodynamic Stability in Malignant Obstructive Jaundice Patients During Peri-Operative Period.
Topics: Atropine; Blood Transfusion; Dexmedetomidine; Female; Hemodynamics; Humans; Jaundice, Obstructive; Kidney; Length of Stay; Male; Middle Aged; Treatment Outcome; Urination | 2019 |
Dexmedetomidine Attenuates Lung Injury in Obstructive Jaundice Rats Through PI3K/Akt/HIF-1α Signaling Pathway.
Topics: Animals; Dexmedetomidine; Jaundice, Obstructive; Lung Injury; Male; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Signal Transduction | 2019 |